By Amber Stanford
May 26, 2012 – The FDA has recently recognized a new study released in the issue May 17, 2012 of the New England Journal of Medicine that reports a small increase in cardiovascular deaths, and in the risk of death from any cause, in persons treated with a 5-day course of azithromycin (Zithromax) compared to persons treated with amoxicillin, ciprofloxacin, or no drug at all. The FDA intends to further review this research any findings.
September 13, 2013 Louisiana Association for Justice Fall Conference Topic: Persuading the 21st Century Jury At the Windsor Court Hotel New Orleans, […]
By Andrea Schmauss August 20, 2013 – In June 2013, at the 40th Anniversary the Denton Cooley, MD Center in Houston, Carolyn […]
By Buck Daniel August 14, 2013 – More than 700 Pradaxa cases have now been filed in the Southern District of Illinois before […]
By Buck Daniel August 14, 2013 – Since our last update, several big developments have occurred in the nationwide Actos litigation. The […]
